Value
- Base
- 189.4
- Cagr
- 7.7
- Currency
- USD
- Forecast
- 342.7
- Unit
- Billion
Graph-backed node
According to Pheonix Research, the Global Dietary Supplements Market is valued at USD 189.4 billion in 2025 and is projected to reach USD 342.7 billion by 2033, registering a CAGR of 7.7% during 2026–2033. North America currently represents the largest regional market and Asia-Pacific is the fastest-growing region, driven by rising disposable income, expanding middle-class populations, and increasing awareness of preventive healthcare across China, India, Japan, and Southeast Asia.
According to Pheonix Research, the Global Dietary Supplements Market is valued at USD 189.4 billion in 2025 and is projected to reach USD 342.7 billion by 2033, registering a CAGR of 7.7% during 2026–2033. North America currently represents the largest regional market and Asia-Pacific is the fastest-growing region, driven by rising disposable income, expanding middle-class populations, and increasing awareness of preventive healthcare across China, India, Japan, and Southeast Asia.
The market is expected to reach USD 342.7 billion by 2033, growing from USD 189.4 billion in 2025 at a CAGR of 7.7%.
Vitamins and mineral supplements lead the market due to their widespread use for immunity, bone health, and overall wellness.
North America is the largest market, while Asia-Pacific is the fastest-growing region driven by rising health awareness and supplement adoption.
Pfizer Inc. is one of the largest companies, along with Abbott Laboratories, Amway Corporation, Herbalife Nutrition, Nestlé Health Science, Glanbia Plc, Nature’s Bounty, and GNC Holdings LLC.
Environment: live
Freshness: 2026-06-12T19:44:36+00:00
Resolved node: MIMR-node_a9917a6
Statsfocus
https://statsfocus.com
Knowledge graph of market intelligence